%3Amax_bytes(150000)%3Astrip_icc()%2FTAL-nakasendo-way-benten-ike-pond-NAKASENDOWAY0425-9682809485154b94ab2bac1288990be7.jpg&w=3840&q=100)
This Peaceful Hiking Route Has Been Walked by Samurais and Monks—and It's an Amazing Way to See Japan's Cherry Blossoms
For centuries, samurai, monks, and nobles journeyed between Kyoto and Tokyo along the Nakasendo—the 330-mile 'road through the mountains.' Once bustling with foot traffic and feudal drama, this ancient trail is now a quiet ribbon winding through forested hills and rural hamlets, far from Japan's well-trodden tourist paths.
Today, a new kind of traveler walks it—those seeking something slower, quieter, and more immersive. To follow the Nakasendo is to walk in the footsteps of merchants and warriors, poets and pilgrims—and to write your own story into its centuries-old landscape.
Walk Japan, a tour company known for its 'off-the-beaten-path' routes through Japan, leads a remarkable 11-day, 10-night journey along the most scenic and storied stretches of the ancient trail. Their Nakasendo Way tour winds through remote countryside, over the Alps of Japan, and into time-preserved villages.
Along the way, travelers will learn about the role of the pathway in the Edo Period and the story behind important battles in Japanese history. And at the end of each day, walking shoes are removed and feet are elevated in traditional Japanese inns, which are renowned for their meals and care.
Walking Nakasendo Way is, quite simply, one of the most peaceful—and spectacular—ways to see Japan. It is a route that is renowned for its cherry blossom trees, which bloom along the trail between March and May.
Although Nakasendo Way is an 11-day journey, Walk Japan is clear that it is a walk, not a trek. It is suitable for anyone who can walk for four to six hours in comfort. Transportation is available for those who need a rest day and baggage is sent ahead to the next destination each morning. Nakasendo Way was rated an Activity Level 3 and Technical Level 3 on a scale of 1–6 by Walk Japan, meaning participants should be able to walk between 6.2 miles to 16 miles (or four to six hours) each day. The route includes some short ascents and descents and takes place on a variety of paths, including pavement, loose gravel, and forest trails. Walking poles are recommended.
Walk Japan's Nakasendo Way is a small-group tour with a maximum of 12 participants and no minimum. It is available from March to June and again from September to November, but it's best done in the spring, when the cherry blossoms bring an added touch of beauty and color.
In addition to Nakasendo Way, Walk Japan's original route, the tour company offers over 38 guided and self-guided tours that weave through rural Japan, including the five-day Kiso Road walk, which is an abridged version of Nakasendo Way.
Pricing for the Nakasendo Way walking tour starts at 575,000 JPY (or just under $4,000 USD). More information on the route, as well as a map, can be found at nakasendoway.com.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Free bonsai exhibition showcases ancient art with modern twist
LONGVIEW, Texas (KTAL/KMSS) — Ancient skills with a modern twist will be on display for free at the Longview Arboretum and Nature Center. For 100s of years, people have studied bonsai. The word bonsai comes from combining the Japanese word for pot or container and word for cultivate. The most simple translation is that bonsai is the art of cultivating dwarf trees. Bonsai is not a specific type of tree; many pines and junipers are typically used. It is any tree that is grown in a pot and artificially prevented from reaching its normal size. Bonsai is also not originally Japanese. Dancing and dirt at Shreveport Green's Volunteer Day Bonsai originated in China by the fourth century and spread to Korea. Through Korea, it spread to Japan by the sixth century and spread further, becoming popular in places around the world. The Gregg County Master Gardeners and the Longview Bonsai Society are holding a bonsai exhibition from June 20 to July 3. On June 27, from 11:30 a.m. to 1 p.m., a special seminar, 'Master the Possibilities: Intro to Bonsai,' will teach the basics of bonsai care and design and provide the opportunity to ask questions about the practice. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
an hour ago
- Yahoo
Canadian Multiple Sclerosis Nurses Among Winners of International Nightingale Award 2025
Four Canadian nurses are among eleven global recipients of the International Nightingale award for excellence in MS nursing. The awards are presented by the International Organization of Multiple Sclerosis Nurses (IOMSN) with support from Merck KGaA, Darmstadt, Germany. MISSISSAUGA, ON, June 4, 2025 /CNW/ - EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, is pleased to announce four Canadian nurses are among the recipients of the International Organization of Multiple Sclerosis Nurses (IOMSN) 2025 International Nightingale Award. The International Nightingale Award was launched in 2020 by IOMSN, with support from Merck KGaA, Darmstadt, Germany in celebration of the International Year of the Nurse and Midwife. "As a company dedicated to advancing multiple sclerosis care for over 25 years, we recognize that MS nurses play a vital role in providing care and support to patients. We are excited to collaborate with the IOMSN in this initiative, which celebrates nursing professionals and supports impactful projects that enhance patient outcomes," said Javed Alam, Managing Director of EMD Serono Canada. Having Canadian recipients of the International Nightingale Award recognizes the significance of MS nurse contributions to patient management and highlights the leadership role that Canadian nurses play on a global level. Shantha George, a community MS nurse practitioner in Edmonton, will receive $5,000 USD to support her Fight Back: Living Well with MS Program, an initiative that focuses on lifestyle management for mental health where patients learn tips to manage anxiety and depression including breathing techniques, drumming and yoga. Stephanie McLeod, a nurse practitioner at the Alberta Neurologic Centre in Calgary will receive $5,000 USD to support the development of a new program to enhance patient and family education, empowering those affected with MS with the knowledge and support they need. Lou-Anne Robertson, a registered nurse at the Central Alberta Multiple Sclerosis Clinic in Red Deer will receive $5,000 USD to support her efforts to raise awareness about the benefits of MS nurse certification for patient care and professional growth. Trudy Campbell, a nurse practitioner at the Halifax MS Clinic, Nova Scotia Health will receive $5,000 USD to support her work on evidence informed, holistic care pathways related to health promotion to support healthy aging for persons with MS. "Since 2020, IOMSN, EMD Serono and Merck KGaA Darmstadt, Germany have proudly celebrated 'The Lady with the Lamp', Florence Nightingale, who is a symbol of compassion, data-driven care, and nursing excellence. The IOMSN Nightingale Awards empower nurses to bring bold ideas to life, driving meaningful change for those living with MS" said Bonnie Blain, President of the IOMSN. " These awards not only recognize achievement but also inspire continued innovation and leadership in nursing. We are thrilled to partner again with Merck KGaA Darmstadt, Germany to present the 2025 International Nightingale Awards. I am honored to celebrate these Canadian Nightingale Recipients whose impactful work has the potential to improve the lives of their patients and resonate across their communities." The International Nightingale Award was awarded to eleven eligible candidates who live and work in countries outside of the United States. Each will receive funding of up to 5000 US Dollars for current projects that require ongoing and/or additional funding for the growth of the program; proposed time-limited projects; personal activities that will support the professional growth and development of an MS nursing professional; and/or nursing research in MS or a related field. About Multiple SclerosisMultiple Sclerosis (MS) is a degenerative autoimmune disease in which the myelin sheath around the nerves in the brain and spinal cord are inflamed and often damaged. It is estimated that approximately 2.3 million people have MS worldwide. Canada has one of the highest rates of MS in the world with one in 385 people living with the disease. While symptoms vary, the most common symptoms of MS include extreme fatigue, lack of coordination, weakness, tingling, impaired sensation, vision problems, bladder problems, cognitive impairment and mood changes. The relapsing forms of MS are the most common type at the time of diagnosis. About the International Organization of Multiple Sclerosis Nurses (IOMSN)Founded on May 30, 1997, International Organization of Multiple Sclerosis Nurses (IOMSN) is the first and only international organization focusing solely on the needs and goals of professional nurses, anywhere in the world, who care for people with multiple sclerosis. Mentoring, educating, networking, sharing - the IOMSN supports nurses in their continuing effort to offer hope. The mission of the IOMSN is the establishment and perpetuation of a specialized branch of nursing in multiple sclerosis; to establish standards of nursing care in multiple sclerosis; to support multiple sclerosis nursing research; and to educate the health care community about multiple sclerosis; and to disseminate this knowledge throughout the world. The ultimate goal of the IOMSN is to improve the lives of all those persons affected by multiple sclerosis through the provision of appropriate healthcare services and to make hope happen! About EMD Serono, CanadaEMD Serono, Canada, is the Canadian biopharmaceutical business of Merck KGaA, Darmstadt, Germany. EMD Serono, Canada has integrated cutting-edge science, innovative products and devices, and industry-leading patient support and access programs. EMD Serono, Canada has deep expertise in neurology, fertility and endocrinology, as well as a robust pipeline of potential therapies in neurology, oncology, immunology and immuno-oncology. Today, EMD Serono, Canada has more than 100 employees across Canada with headquarters in Mississauga, Merck KGaA, Darmstadt, GermanyMerck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and performance materials. Around 56,000 employees work to make a positive difference to millions of people's lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2018, Merck KGaA, Darmstadt, Germany, generated sales of € 14.8 billion in 66 company holds the global rights to the name and trademark "Merck" internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Performance Materials. Since its founding in 1668, scientific exploration and responsible entrepreneurship have been key to the company's technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company. SOURCE EMD Serono Canada View original content to download multimedia: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
How did humans evolve such rotten genetics?
To Shakespeare's Hamlet we humans are 'the paragon of animals'. But recent advances in genetics are suggesting that humans are far from being evolution's greatest achievement. For example, humans have an exceptionally high proportion of fertilised eggs that have the wrong number of chromosomes and one of the highest rates of harmful genetic mutation. In my new book The Evolution of Imperfection I suggest that two features of our biology explain why our genetics are in such a poor state. First, we evolved a lot of our human features when our populations were small and second, we feed our young across a placenta. Get your news from actual experts, straight to your inbox. Sign up to our daily newsletter to receive all The Conversation UK's latest coverage of news and research, from politics and business to the arts and sciences. Our reproduction is notoriously risky for both mother and embryo. For every child born another two fertilised eggs never made it. Most human early embryos have chromosomal problems. For older mothers, these embryos tend to have too many or too few chromosomes due to problems in the process of making eggs with just one copy of each chromosome. Most chromosomally abnormal embryos don't make it to week six so are never a recognised pregnancy. About 15% of recognised pregnancies spontaneously miscarry, usually before week 12, rising to 65% in women over 40. About half of miscarriages are because of chromosomal issues. Other mammals have similar chromosome-number problems but with an error rate of about 1% per chromosome. Cows should have 30 chromosomes in sperm or egg but about 30% of their fertilised eggs have odd chromosome numbers. Humans with 23 chromosomes should have about 23% of fertilised eggs with the wrong number of chromosomes but our rate is higher in part because we presently reproduce late and chromosomal errors escalate with maternal age. Survive that, then gestational diabetes and high blood pressures issues await, most notably pre-eclampsia, potentially lethal to mother and child, affecting about 5% of pregnancies. It is unique to humans. Historically, up until about 1800, childbirth was remarkably dangerous with about 1% maternal mortality risk, largely owing to pre-eclampsia, bleeding and infection. In Japanese macaques by contrast, despite offspring also having a large head, maternal mortality isn't seen. Advances in maternal care have seen current UK maternal mortality rates plummet to 0.01%. Many of these problems are contingent on the placenta. Compare us to a kiwi bird that loads its large egg with resources and sits on it, even if it is dead: time and energy wasted. In mammals, if the embryo is not viable, the mother may not even know she had conceived. The high rate of chromosomal issues in our early embryos is a mammalian trait connected to the fact that early termination of a pregnancy lessens the costs, meaning less time wasted holding onto a dead embryo and not giving up the resources that are needed for a viable embryo to grow into a baby. But reduced costs are not enough to explain why chromosomal problems are so common in mammals. During the process of making a fertilisable egg with one copy of each chromosome, a sister cell is produced, called the polar body. It's there to discard half of the chromosomes. It can 'pay' in evolutionary terms for a chromosome to not go to the polar body when it should instead stay behind in the soon to be fertilised egg. It forces redirection of resources to viable offspring. This can explain why chromosomal errors are mostly maternal and why, given their lack of ability to redirect saved energy, other vertebrates don't seem to have embryonic chromosome problems. Our problems with gestational diabetes are a consequence of foetuses releasing chemicals from the placenta into the mother's blood to keep glucose available. The problems with pre-eclampsia are associated with malfunctioning placentas, in part owing to maternal immune rejection of the foetus. Regular unprotected sex can protect women against pre-eclampsia by helping the mother become used to paternal proteins. The fact that pre-eclampsia is human-specific may be related to our exceptionally invasive placenta that burrows deep into the uterine lining, possibly required to build our unusually large brains. Our other peculiarities are predicted by the most influential evolutionary theory of the last 50 years, the nearly-neutral theory. It states that natural selection is less efficient when a species has few individuals. A slightly harmful mutation can be removed from a population if that population is large but can increase in frequency, by chance, if the population is small. Most human-specific features evolved when our population size was around 10,000 in Africa prior to its recent (last 20,000 years) expansion. Minuscule compared to, for example, bacterial populations. This explains why we have such a bloated genome. The main job of DNA is to give instructions to our cells about how to make the proteins vital for life. That is done by just 1% of our DNA but by 85% of that of our gut-dwelling bacteria Escherichia coli. Some of our DNA is required for other reasons, such as controlling which genes get activated and when. Yet only about 10% of our DNA shows any signs of being useful. If you have a small population size, you also have more problems stopping genetical errors like mutations. Although DNA mutations can be beneficial, they are more commonly a curse. They are the basis of genetic diseases, be they complex (such as Crohn's disease and predispositions to cancer), or owing to single gene effects (like cystic fibrosis and Huntington's disease). We have one of the highest mutation rates of all species. Other species with massive populations have mutation rates over three orders of magnitude lower, another prediction of the nearly-neutral theory. A consequence of our high mutation rate is that around 5% of us suffer a 'rare' genetic disease. Modern medicine may help cure our many ailments, but if we can't do anything about our mutation rate, we will still get ill. This article is republished from The Conversation under a Creative Commons license. Read the original article. Laurence D. Hurst is the author of The Evolution of Imperfection, published by Princeton University Press. This was enabled by funding from The Humboldt Foundation and the European Research Council.
